The renowned Faculty and Staff at The Corinne Goldsmith Dickinson Center for Multiple Sclerosis include the following:

Fred D. Lublin, M.D. is an international authority on the clinical and scientific aspects of MS and has been recognized as one of the foremost experts in experimental therapies. He is the Director of The Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai, and is the Saunders Family Professor of Neurology at Mount Sinai Medical Center. As a neuroimmunologist, Dr. Lublin has a special interest in immune functions and abnormalities affecting the nervous system. He and his colleagues were among the first in the country involved with studies of Interferon beta-1b. He is currently involved in several new clinical research protocols on promising agents for treating various aspects of MS, and is the National Coordinating Investigator for a multi-center trial of combination therapy in MS.

Aaron E. Miller, M.D. is a professor of Neurology at Mount Sinai and Medical Director at the CGD Center for MS. Recruited to direct clinical affairs at the Center, Dr. Miller is widely recognized for his preeminence as a clinician.  Dr. Miller became the chief medical officer and chairman of the Medical Advisory Board of the National Multiple Sclerosis Society (NMSS) in 2001, and served as chairman of the Clinical Advisory Committee of the New York chapter of the NMSS from 1991-2004. He was the first chairman of the Multiple Sclerosis section of the American Academy of Neurology, and currently serves as Editor of Continuum, AAN’s bimonthly continuing education publication.

Tracy M. DeAngelis, M.D. is an attending physician at the CGD Center and is an assistant professor in the department of Neurology of Mount Sinai. She is the recipient of the National Multiple Sclerosis Society Clinical Fellowship for 2006-07. During residency at Mount Sinai Medical Center, she participated in basic immunology research, and later as a fellow was involved in several ongoing clinical research trials studying various patterns of MS. Dr. DeAngelis has a particular interest in the pathophysiology and treatment of Neuromyelitis Optica, also known as Devic’s disease, and NMO-spectrum disorders.

Stephen Krieger, M.D. is an attending physician at the CGD Center and is assistant professor of neurology. He joined the Center as a Fellow in MS in 2006 after completing his Neurology residency training at Mount Sinai. He is the recipient of a 2006 American Academy of Neurology Scholarship, and the Sylvia Lawry Fellowship in clinical research from the National MS Society. A graduate of Columbia College, he received his MD degree from Yale University, and completed his medical internship at St. Vincent's Hospital, Manhattan. Dr. Krieger is currently participating in research on a variety of MS clinical trials and is studying clinical research design. As part of his involvement in medical education, he leads a monthly seminar on neuro-ethics for the Mount Sinai medical school. His professional interests include multiple sclerosis, neuropsychiatry and behavior, and modern neuroimaging techniques.

Krupa Pandey, M.D., Senior Fellow, is the recipient of the 2007 National Multiple Sclerosis Society's Clinical Fellowship Award and the 2008 Brigham and Women's Clinical Fellowship Award. She joined the faculty at the Center in 2006, having completed her residency at Georgetown University Medical Center where she served as Administrative Chief Resident. Dr. Pandey is currently conducting research on factors that initiate, delay, or alter progression in primary-progressive and secondary-progressive phases of MS. She serves as co-investigator in a range of clinical trials underway at the Center. She is especially interested in neuromyelitis optica and progressive forms of MS.

Pavle Repovic, M.D., Ph.D., Junior Fellow, is a recipient of the Sylvia Lawry Physician Award from the National MS Society. He completed his medical training at the University of Alabama in Birmingham, and his neurology residency at Cornell-New York Presbyterian Hospital. His doctoral work in neuroimmunology been published in leading peer-reviewed journals. He is interested in studying the tumefactive form of multiple sclerosis and ways to translate neuroscience to the clinical care of patients with MS.

Aliza Ben-Zacharia, C.R.R.N., M.S.N., A.N.P.-B.C. is a board-certified nurse practitioner with years of experience in acute care and rehabilitation.  She provides direct patient care, follow-up, and training for patients and their loved ones, as well as assisting in clinical trials. A skilled educator, Aliza has developed educational programs for patients and professionals, and has published articles and chapters about MS, disease-modifying agents, symptom management, and palliative care. She is a certified MS nurse, and is a member of the board of the International Organization of Multiple Sclerosis Nurses.

Jennifer Decker, M.S.N., A.N.P.-B.C., C.N.R.N., M.S.C.N. is a highly-trained nurse practitioner with board certification in neuroscience and multiple sclerosis.  She provides direct patient care, education, and training for patients, and she assists in clinical trials.  Jennifer has had prior experience as a nurse in cardiothoracic intensive care, and as a nurse practitioner in neurosurgery.  She received her Master’s degree in nursing from Yale University.

Michele Weber, M.S., C.C.R.C. heads the CGD Center’s Research division, as Clinical Trials Manager. She ensures that the research coordinators execute the various important multilevel tasks in clinical research, and observe and evaluate the patients’ medical condition.

Tova Epstein L.C.S.W., and Donna Siegal, L.C.S.W., are the Social Workers for the CGD Center, and provide support to patients and their loved ones in matters related to the patient’s condition, treatment, and social-service needs.

Donna Polisar, Ph.D. is the MS Center’s Administrator and is responsible for the business operations of the facility.